An Analysis of Toxicities and Time to Engraftment Associated with Three Distinct Melphalan Treatment Schemas in Patients with Multiple Myeloma Receiving Autologous Hematopoetic Stem Cell Transplantation.

被引：0
|
作者：
Maewal, Ila [1 ]
Kurtzweil, Andy J. [1 ]
Shapiro, Jamie F.
Westmoreland, Michael D. [1 ]
Bassett, Roland L. [2 ]
Giralt, Sergio
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Houston, TX USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：753 / 753
页数：1
相关论文
共 50 条
  • [1] AN ANALYSIS OF TOXICITIES AND TIME TO ENGRAFTMENT ASSOCIATED WITH THREE DISTINCT MELPHALAN TREATMENT SCHEMAS IN PATIENTS WITH MULTIPLE MYELOMA RECEIVING AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION
    Maewal, L.
    Kurtzweil, A. Y.
    Shapiro, J. F.
    Westmoreland, M. D.
    Bassett, R. L., Jr.
    Giralt, S. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 155 - 155
  • [2] The effect of melphalan administration time on engraftment in multiple myeloma patients undergoing autologous stem cell transplantation
    Unal, Ali
    Yildizhan, Esra
    Kaynar, Leylagul
    Varal, Fatma
    Ciftci, Sibel
    Coskun, Elmas
    Yildiz, Gulseren
    Yanar, Ayse
    Eser, Bulent
    Cetin, Mustafa
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 293
  • [3] TREATMENT OF MULTIPLE MYELOMA PATIENTS WITH TANDEM AUTOLOGOUS HEMATOPOETIC STEM CELL TRANSPLANTATION IN SLOVENIJA
    Zver, Aleksandra
    Zver, Samo
    Mlakar, Uros
    Zupan, Irena Preloznik
    Pretnar, Joze
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2008, 77 : I75 - I80
  • [4] Safety of therapeutic anticoagulation in patients with multiple myeloma receiving autologous stem cell transplantation.
    Schimmer, AD
    MacKinnon, J
    Meharchand, J
    Keating, A
    Crump, RM
    Sutton, DM
    Shepherd, FA
    Stewart, AK
    BLOOD, 1997, 90 (10) : 4387 - 4387
  • [5] Factors Affecting Time to Engraftment During Autologous Stem Cell Transplantation in Patients With Multiple Myeloma *
    Bolaman, Ali Z.
    Turgutkaya, Atakan
    Yavasoglu, Irfan
    PLASMATOLOGY, 2021, 15
  • [6] Cardiotoxicity in patients with multiple myeloma treated with tandem autologous hematopoetic stem cell transplantation
    Zver, Samo
    Kozelj, Mirta
    Mlakar, Uros
    BLOOD, 2007, 110 (11) : 306B - 306B
  • [7] REVACCINATING MULTIPLE MYELOMA PATIENTS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION.
    Bennett, Jenifer
    DeLeon, Sierra
    Schaindlin, Patricia
    ONCOLOGY NURSING FORUM, 2010, 37 (03) : E262 - E262
  • [8] SUCCESSFUL STEM CELL MOBILIZATION AND ENGRAFTMENT IN HEAVILY PRETREATED MULTIPLE MYELOMA PATIENTS WITH PRIOR HIGH DOSE MELPHALAN AND AUTOLOGOUS STEM CELL TRANSPLANTATION
    Khaled, Y.
    Solh, M.
    Lamontagne, D.
    Batista, A.
    Sullivan, Y.
    Chan-Fong, S.
    Fondaw, M.
    Reddy, V
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S300 - S300
  • [9] Melphalan and dexamethasone for patients with multiple myeloma who are not candidates for autologous stem cell transplantation
    Sharma, Atul
    Lokeshwar, Nilesh
    Raina, Vinod
    Mohanti, Bidhu K.
    Kumar, Rajive
    NATIONAL MEDICAL JOURNAL OF INDIA, 2007, 20 (03): : 121 - 124
  • [10] Intensive therapy with bortezomib and melphalan and autologous stem cell transplantation for patients with multiple myeloma
    Luo, Y.
    Tan, Y.
    He, J.
    Shi, J.
    Wu, W.
    Han, X.
    Zheng, G.
    Wei, G.
    Zheng, W.
    Ye, X.
    Cai, Z.
    Huang, H.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S264 - S264
12345